Macrogenics Inc (MGNX)
4.34
-0.21
(-4.62%)
USD |
NASDAQ |
May 28, 16:00
4.325
-0.02
(-0.35%)
After-Hours: 20:00
Macrogenics Gross Profit Margin (Quarterly): 76.76% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 76.76% |
December 31, 2023 | 98.22% |
September 30, 2023 | 67.69% |
June 30, 2023 | 91.04% |
March 31, 2023 | 85.62% |
December 31, 2022 | 97.48% |
September 30, 2022 | 92.47% |
Date | Value |
---|---|
June 30, 2022 | 90.76% |
March 31, 2022 | 99.55% |
December 31, 2021 | 92.33% |
September 30, 2021 | 89.37% |
June 30, 2021 | 99.93% |
March 31, 2021 | 99.89% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
67.69%
Minimum
Sep 2023
99.93%
Maximum
Jun 2021
90.86%
Average
92.33%
Median
Dec 2021
Gross Profit Margin (Quarterly) Benchmarks
Moderna Inc | 42.52% |
Allurion Technologies Inc | 73.15% |
Novavax Inc | 36.91% |
United Therapeutics Corp | 89.24% |
MEI Pharma Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -15.84% |
Return on Assets | -7.57% |
Return on Invested Capital | -15.84% |
Profit Margin (Quarterly) | -573.3% |
Operating Margin (Quarterly) | -590.4% |
Return on Net Operating Assets | -34.99% |